{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:12:15Z","timestamp":1792843935736,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jconrel.2022.08.056","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T23:53:28Z","timestamp":1663113208000},"page":"857-869","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Active transport nanochelators for the reduction of liver iron burden in iron overload"],"prefix":"10.1016","volume":"350","author":[{"given":"Srinivas","family":"Abbina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usama","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshdeep","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Leitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayachandran N.","family":"Kizhakkedathu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.08.056_bb0005","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.bbamcr.2006.03.014","article-title":"Regulation of iron acquisition and iron distribution in mammals","volume":"1763","author":"Ganz","year":"2006","journal-title":"Biochim. Biophys. Acta BBA Mol. Cell Res."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0010","doi-asserted-by":"crossref","first-page":"12735","DOI":"10.1074\/jbc.R117.786632","article-title":"Iron transport proteins: gateways of cellular and systemic iron homeostasis","volume":"292","author":"Knutson","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0015","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1021\/acschembio.1c00122","article-title":"Role of iron in the molecular pathogenesis of diseases and therapeutic opportunities","volume":"16","author":"Abbasi","year":"2021","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0020","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1182\/blood-2013-06-427757","article-title":"The liver: conductor of systemic iron balance","volume":"123","author":"Meynard","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0025","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132964","article-title":"Regulation of tissue iron homeostasis: the macrophage \u201cferrostat\u201d","volume":"5","author":"Winn","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0030","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMra031573","article-title":"Hereditary hemochromatosis \u2014 a new look at an old disease","volume":"350","author":"Pietrangelo","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jhep.2008.11.011","article-title":"Iron in NASH, chronic liver diseases and HCC: how much iron is too much?","volume":"50","author":"Pietrangelo","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0040","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1038\/modpathol.3800715","article-title":"Iron overload syndromes and the liver","volume":"20","author":"Batts","year":"2007","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0045","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jhep.2011.05.008","article-title":"Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target","volume":"55","author":"Dongiovanni","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0050","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/hep4.1190","article-title":"Hepatic iron concentration correlates with insulin sensitivity in nonalcoholic fatty liver disease","volume":"2","author":"Britton","year":"2018","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/hep.1840060106","article-title":"Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis","volume":"6","author":"Bassett","year":"1986","journal-title":"Hepatol. Baltim. Md."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/bjh.13374","article-title":"Estimating tissue Iron burden: current status and future prospects","volume":"170","author":"Wood","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2630-3","article-title":"Hepatic iron overload is associated with hepatocyte apoptosis during Clonorchis sinensis infection","volume":"17","author":"Han","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0070","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/HCO.0000000000000511","article-title":"Iron overload cardiomyopathy: from diagnosis to management","volume":"33","author":"D\u00edez-L\u00f3pez","year":"2018","journal-title":"Curr. Opin. Cardiol."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0075","doi-asserted-by":"crossref","first-page":"19502","DOI":"10.1074\/jbc.273.31.19502","article-title":"Mechanism of N-acetylgalactosamine binding to a C-type animal lectin carbohydrate-recognition domain *","volume":"273","author":"Kolatkar","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0021-9258(18)33240-X","article-title":"Binding of synthetic oligosaccharides to the hepatic gal\/GalNAc lectin. Dependence on fine structural features","volume":"258","author":"Lee","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0085","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0021-9258(19)68290-6","article-title":"Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation","volume":"257","author":"Connolly","year":"1982","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0090","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/bc050113d","article-title":"A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization","volume":"16","author":"Popielarski","year":"2005","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0095","doi-asserted-by":"crossref","first-page":"37577","DOI":"10.1074\/jbc.M101786200","article-title":"Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo","volume":"276","author":"Rensen","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0100","series-title":"Lipid Nanoparticles Incorporating a GalNAc Ligand Enable In Vivo Liver ANGPTL3 Editing in Wild-Type and Somatic LDLR Knockout Non-Human Primates","author":"Kasiewicz","year":"2021"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0105","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1021\/jacs.6b12964","article-title":"Efficient liver targeting by polyvalent display of a compact ligand for the asialoglycoprotein receptor","volume":"139","author":"Sanhueza","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0110","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0115","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.ymthe.2021.06.002","article-title":"Ligand conjugate SAR and enhanced delivery in NHP","volume":"29","author":"Holland","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ymthe.2017.08.019","article-title":"Evaluation of GalNAc-siRNA conjugate activity in pre-clinical animal models with reduced asialoglycoprotein receptor expression","volume":"26","author":"Willoughby","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0125","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1016\/j.biomaterials.2010.11.005","article-title":"The labeling of cationic iron oxide nanoparticle-resistant hepatocellular carcinoma cells using targeted magnetoliposomes","volume":"32","author":"Soenen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0130","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0168-8278(94)80243-2","article-title":"Specific targeting of the antiviral drug 5-Iodo 2\u2032-deoxyuridine to the parenchymal liver cell using lactosylated poly-L-lysine","volume":"21","author":"Biessen","year":"1994","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0135","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1080\/19420862.2017.1373924","article-title":"Capacity limits of asialoglycoprotein receptor-mediated liver targeting","volume":"9","author":"Bon","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0140","doi-asserted-by":"crossref","first-page":"11295","DOI":"10.1016\/S0021-9258(19)38590-4","article-title":"Molecular cloning and sequence analysis of cDNA encoding the macrophage lectin specific for galactose and N-acetylgalactosamine","volume":"265","author":"Ii","year":"1990","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mce.2003.06.001","article-title":"The RHL-1 subunit of the asialoglycoprotein receptor of thyroid cells: cellular localization and its role in thyroglobulin endocytosis","volume":"208","author":"Pacifico","year":"2003","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0150","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000064283","article-title":"Expression of a functional asialoglycoprotein receptor in human renal proximal tubular epithelial cells","volume":"91","author":"Seow","year":"2002","journal-title":"Nephron"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0155","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jconrel.2015.02.022","article-title":"Asialoglycoprotein receptor mediated hepatocyte targeting \u2014 strategies and applications","volume":"203","author":"D\u2019Souza","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0160","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156720108785915069","article-title":"Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development","volume":"5","author":"Li","year":"2008","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0165","doi-asserted-by":"crossref","first-page":"9249","DOI":"10.1039\/C7TB02515G","article-title":"Hyperbranched polyglycerols: recent advances in synthesis, biocompatibility and biomedical applications","volume":"5","author":"Abbina","year":"2017","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0170","doi-asserted-by":"crossref","DOI":"10.1021\/acscentsci.9b00284","article-title":"Design of Safe Nanotherapeutics for the excretion of excess systemic toxic Iron","author":"Abbina","year":"2019","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.31","article-title":"Elucidation of the biotransformation pathways of a Galnac3-conjugated antisense oligonucleotide in rats and monkeys","volume":"5","author":"Shemesh","year":"2016","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0180","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13143-z","article-title":"Renal clearable nanochelators for iron overload therapy","volume":"10","author":"Kang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0185","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1038\/s41598-021-85387-z","article-title":"A facile colorimetric method for the quantification of labile iron pool and total iron in cells and tissue specimens","volume":"11","author":"Abbasi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0190","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1182\/blood-2009-05-224188","article-title":"Specific iron chelators determine the route of ferritin degradation","volume":"114","author":"De Domenico","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0195","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1503\/cmaj.1040752","article-title":"Liver enzyme alteration: a guide for clinicians","volume":"172","author":"Giannini","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0200","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1532-429X-11-20","article-title":"The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study","volume":"11","author":"Berdoukas","year":"2009","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0205","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.V95.4.1229.004k32_1229_1236","article-title":"Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia","volume":"95","author":"Davis","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0210","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/trf.12335","article-title":"Combination therapy of deferasirox and deferoxamine shows significant improvements in markers of iron overload in a patient with \u03b2-thalassemia major and severe iron burden","volume":"54","author":"Voskaridou","year":"2014","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2008.05.024","article-title":"Receptor targeted polymers, dendrimers, liposomes: which nanocarrier is the most efficient for tumor-specific treatment and imaging?","volume":"130","author":"Saad","year":"2008","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0220","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jconrel.2014.04.013","article-title":"Macromolecular therapeutics","volume":"190","author":"Yang","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0225","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.1021\/acs.chemrev.5b00589","article-title":"Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies","volume":"116","author":"Ulbrich","year":"2016","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0230","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/s41565-019-0591-y","article-title":"The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs","volume":"14","author":"Akinc","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0235","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3164\/jcbn.10-76","article-title":"Iron regulation by hepatocytes and free radicals","volume":"48","author":"Takami","year":"2011","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0240","doi-asserted-by":"crossref","first-page":"12727","DOI":"10.1074\/jbc.R117.781823","article-title":"Iron homeostasis: an anthropocentric perspective","volume":"292","author":"Coffey","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0245","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2005.01.026","article-title":"Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting","volume":"295","author":"Bhadra","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0250","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2014.05.016","article-title":"Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice","volume":"193","author":"Zou","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0255","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/bjc.1991.190","article-title":"N-(2-hydroxypropyl)methacrylamide copolymers targeted to the hepatocyte galactose-receptor: pharmacokinetics in DBA2 mice","volume":"63","author":"Seymour","year":"1991","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0260","doi-asserted-by":"crossref","first-page":"16958","DOI":"10.1021\/ja505986a","article-title":"Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing","volume":"136","author":"Nair","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0265","doi-asserted-by":"crossref","first-page":"10108","DOI":"10.1073\/pnas.86.24.10108","article-title":"Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers","volume":"86","author":"Hallaway","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0270","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1021\/acs.nanolett.8b02428","article-title":"Polymeric nanoparticles enhance the ability of deferoxamine to deplete hepatic and systemic iron","volume":"18","author":"Guo","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0275","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1021\/acsnano.0c01083","article-title":"Reactive oxygen species-triggered dissociation of a polyrotaxane-based nanochelator for enhanced clearance of systemic and hepatic Iron","volume":"15","author":"Liu","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2022.08.056_bb0280","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1046\/j.1365-2141.2003.04297.x","article-title":"Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with \u03b2-thalassaemia major: application of SQUID biomagnetic liver susceptometry","volume":"121","author":"Fischer","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jconrel.2022.08.056_bb0285","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ajh.10348","article-title":"Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity","volume":"73","author":"Chaston","year":"2003","journal-title":"Am. J. Hematol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592200579X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592200579X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:37:24Z","timestamp":1759163844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592200579X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":57,"alternative-id":["S016836592200579X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.056","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active transport nanochelators for the reduction of liver iron burden in iron overload","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}